129 related articles for article (PubMed ID: 31980082)
41. Detection of Cryptic Mosaicism in X-linked Alport Syndrome Prompts to Re-evaluate Living-donor Kidney Transplantation.
Pinto AM; Daga S; Fallerini C; Bruttini M; Baldassarri M; Giliberti A; Frullanti E; Guarnieri A; Garosi G; Renieri A
Transplantation; 2020 Nov; 104(11):2360-2364. PubMed ID: 31895869
[TBL] [Abstract][Full Text] [Related]
42. Temporal retinal thinning and the diagnosis of Alport syndrome and Thin basement membrane nephropathy.
Chen Y; Colville D; Ierino F; Symons A; Savige J
Ophthalmic Genet; 2018 Apr; 39(2):208-214. PubMed ID: 29172845
[TBL] [Abstract][Full Text] [Related]
43. Genotype-phenotype correlation in X-linked Alport syndrome patients carrying missense mutations in the collagenous domain of COL4A5.
Tsiakkis D; Pieri M; Koupepidou P; Demosthenous P; Panayidou K; Deltas C
Clin Genet; 2012 Sep; 82(3):297-9. PubMed ID: 22335431
[No Abstract] [Full Text] [Related]
44. Mechanical response of wild-type and Alport murine lens capsules during osmotic swelling.
Gyoneva L; Segal Y; Dorfman KD; Barocas VH
Exp Eye Res; 2013 Aug; 113():87-91. PubMed ID: 23707242
[TBL] [Abstract][Full Text] [Related]
45. Crescentic and necrotising glomerulonephritis: a rare histological manifestation of Alport syndrome.
Moyano Crespo GD; Torres AI; Mukdsi JH
J Clin Pathol; 2015 Jul; 68(7):581-3. PubMed ID: 25869794
[No Abstract] [Full Text] [Related]
46. A Novel Mutation in a Kazakh Family with X-Linked Alport Syndrome.
Baikara BT; Zholdybayeva EV; Rakhimova SE; Nigmatullina NB; Momynaliev KT; Ramanculov YM
PLoS One; 2015; 10(7):e0132010. PubMed ID: 26168235
[TBL] [Abstract][Full Text] [Related]
47. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.
Hudson BG; Kalluri R; Gunwar S; Weber M; Ballester F; Hudson JK; Noelken ME; Sarras M; Richardson WR; Saus J
Kidney Int; 1992 Jul; 42(1):179-87. PubMed ID: 1635348
[TBL] [Abstract][Full Text] [Related]
48. The retinal "lozenge" or "dull macular reflex" in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure.
Colville D; Wang YY; Tan R; Savige J
Br J Ophthalmol; 2009 Mar; 93(3):383-6. PubMed ID: 19019929
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical and molecular genetic evidence for type IV collagen alpha5 chain abnormality in the anterior lenticonus associated with Alport syndrome.
Ohkubo S; Takeda H; Higashide T; Ito M; Sakurai M; Shirao Y; Yanagida T; Oda Y; Sado Y
Arch Ophthalmol; 2003 Jun; 121(6):846-50. PubMed ID: 12796257
[TBL] [Abstract][Full Text] [Related]
50. [Application of multiplex ligation-dependent probe amplification in gene diagnosis of X-linked Alport syndrome].
Zhang YQ; Zhao D; Yu LX; Ding J; Wang F
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2825-9. PubMed ID: 23290210
[TBL] [Abstract][Full Text] [Related]
51. Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum.
Caliskan Y; Lentine KL
Pediatr Nephrol; 2022 Sep; 37(9):1981-1994. PubMed ID: 35088158
[TBL] [Abstract][Full Text] [Related]
52. Ocular features in Alport syndrome: pathogenesis and clinical significance.
Savige J; Sheth S; Leys A; Nicholson A; Mack HG; Colville D
Clin J Am Soc Nephrol; 2015 Apr; 10(4):703-9. PubMed ID: 25649157
[TBL] [Abstract][Full Text] [Related]
53. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.
Savige J
Pediatr Nephrol; 2020 Jan; 35(1):59-66. PubMed ID: 30506145
[TBL] [Abstract][Full Text] [Related]
54. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
[TBL] [Abstract][Full Text] [Related]
55. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
[TBL] [Abstract][Full Text] [Related]
56. Raising the Volume on Alport Syndrome: A Patient Perspective.
Dunleavy ME
Kidney360; 2020 Apr; 1(4):227-228. PubMed ID: 35372919
[No Abstract] [Full Text] [Related]
57. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
[TBL] [Abstract][Full Text] [Related]
58. Discordance between skin biopsy and kidney biopsy in an X-linked carrier of Alport syndrome.
Hamiwka LA; George DH; Grisaru S; Midgley JP
Pediatr Nephrol; 2007 Jul; 22(7):1050-3. PubMed ID: 17294221
[TBL] [Abstract][Full Text] [Related]
59. Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation.
Petzold F; Bachmann A; Bergmann C; Helmchen U; Halbritter J
BMC Nephrol; 2019 Sep; 20(1):340. PubMed ID: 31477057
[TBL] [Abstract][Full Text] [Related]
60. [Detection of a novel mutation in COL4A5 gene from a Chinese family with X-linked alport syndrome].
Peng CL; Liang H; Z ou QL; Wang J; Liu CS; Zhang XF; Chen J; Hu SN
Yi Chuan Xue Bao; 2004 Nov; 31(11):1190-5. PubMed ID: 15651669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
